Microsoft to Acquire Rosetta Biosoftware from Merck

Microsoft inked a deal to acquire Rosetta Biosoftware, which will add genetic, genomic, metabolomic, and proteomic data management software to its own Amalga Life Sciences platform.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.